Wang, Shu
Wang, Jingya
Kumar, Varsha
Karnell, Jodi L.
Naiman, Brian
Gross, Phillip S. http://orcid.org/0000-0003-2642-6504
Rahman, Saifur
Zerrouki, Kamelia
Hanna, Richard
Morehouse, Christopher
Holoweckyj, Nicholas
Liu, Hao
Casey, Kerry
Smith, Michael
Parker, Melissa
White, Natalie
Riggs, Jeffrey
Ward, Beth
Bhat, Geetha
Rajan, Bhargavi
Grady, Rebecca
Groves, Chris
Manna, Zerai
Goldbach-Mansky, Raphaela
Hasni, Sarfaraz http://orcid.org/0000-0002-4164-8837
Siegel, Richard
Sanjuan, Miguel
Streicher, Katie
Cancro, Michael P.
Kolbeck, Roland
Ettinger, Rachel http://orcid.org/0000-0003-3761-9571
,
Article History
Received: 12 October 2017
Accepted: 8 March 2018
First Online: 1 May 2018
Competing interests
: S.W., J.W., V.K., B.N., S.R., K.Z., R.H., C.M., H.L., N.H., Autoimmunity Molecular Medicine Team, K.S. and R.K. are full-time employees and shareholders of MedImmune/AstraZeneca. R.E. and J.L.K. were employees at MedImmune and owners of AstraZeneca stock. They are currently employees at and shareholder at Viela Bio. The remaining authors declare no competing interests.